Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of AR10 (Acetylcysteine Effervescent Tablets) vs Reference in Healthy Adults
NCT02723669Phase 1Completed
- Start
- Apr 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of acetylcysteine in acetaminophen toxicity (2 arms). Primary endpoints: Area Under the Curve at 10 days and Maximum Plasma Concentration at 10 days. Started Apr 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
acetaminophen toxicity
Beyond the preview
Go deeper on NCT02723669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02723669.